Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02415205 · ClinicalTrials.gov registry record
Pain and Stress Assessment and ROP Screening
A clinical trial, sponsored by Loma Linda University.
- Completed
- Registry status
- 42
- Enrollment target
NCT02415205: Completed study, sponsored by Loma Linda University.
NCT02415205 is a clinical trial that has completed, run by Loma Linda University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02415205 has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The study will measure the effects of eye exams on markers of stress in the urine. In addition, measurements will be taken to show the effects of stress on brain activity, O2 sats, and blood flow.
Primary Outcome
Collection to occur 3-4 hours before eye exam and 24 hours after the eye exam.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-12 |
What the finished NCT02415205 record still lists
NCT02415205 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02415205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02415205 about?
NCT02415205 is a clinical study titled "Pain and Stress Assessment and ROP Screening". The study will measure the effects of eye exams on markers of stress in the urine. In addition, measurements will be taken to show the effects of stress on brain activity, O2 sats, and blood flow.
What is the current status of trial NCT02415205?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2015-04. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT02415205?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia